281 related articles for article (PubMed ID: 17556201)
1. Arrhythmogenic consequences of Na+ channel mutations in the transmurally heterogeneous mammalian left ventricle: analysis of the I1768V SCN5A mutation.
Flaim SN; Giles WR; McCulloch AD
Heart Rhythm; 2007 Jun; 4(6):768-78. PubMed ID: 17556201
[TBL] [Abstract][Full Text] [Related]
2. Contributions of sustained INa and IKv43 to transmural heterogeneity of early repolarization and arrhythmogenesis in canine left ventricular myocytes.
Flaim SN; Giles WR; McCulloch AD
Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2617-29. PubMed ID: 16829642
[TBL] [Abstract][Full Text] [Related]
3. Effects of L-type Ca2+ channel antagonism on ventricular arrhythmogenesis in murine hearts containing a modification in the Scn5a gene modelling human long QT syndrome 3.
Thomas G; Gurung IS; Killeen MJ; Hakim P; Goddard CA; Mahaut-Smith MP; Colledge WH; Grace AA; Huang CL
J Physiol; 2007 Jan; 578(Pt 1):85-97. PubMed ID: 17110414
[TBL] [Abstract][Full Text] [Related]
4. Transmural dispersion of repolarization and arrhythmogenicity: the Brugada syndrome versus the long QT syndrome.
Antzelevitch C; Yan GX; Shimizu W
J Electrocardiol; 1999; 32 Suppl():158-65. PubMed ID: 10688320
[TBL] [Abstract][Full Text] [Related]
5. Effects of flecainide and quinidine on arrhythmogenic properties of Scn5a+/Delta murine hearts modelling long QT syndrome 3.
Stokoe KS; Thomas G; Goddard CA; Colledge WH; Grace AA; Huang CL
J Physiol; 2007 Jan; 578(Pt 1):69-84. PubMed ID: 17023504
[TBL] [Abstract][Full Text] [Related]
6. A novel LQT3 mutation implicates the human cardiac sodium channel domain IVS6 in inactivation kinetics.
Groenewegen WA; Bezzina CR; van Tintelen JP; Hoorntje TM; Mannens MM; Wilde AA; Jongsma HJ; Rook MB
Cardiovasc Res; 2003 Mar; 57(4):1072-8. PubMed ID: 12650885
[TBL] [Abstract][Full Text] [Related]
7. Knock-in gain-of-function sodium channel mutation prolongs atrial action potentials and alters atrial vulnerability.
Blana A; Kaese S; Fortmüller L; Laakmann S; Damke D; van Bragt K; Eckstein J; Piccini I; Kirchhefer U; Nattel S; Breithardt G; Carmeliet P; Carmeliet E; Schotten U; Verheule S; Kirchhof P; Fabritz L
Heart Rhythm; 2010 Dec; 7(12):1862-9. PubMed ID: 20728579
[TBL] [Abstract][Full Text] [Related]
8. Long-QT syndrome-related sodium channel mutations probed by the dynamic action potential clamp technique.
Berecki G; Zegers JG; Bhuiyan ZA; Verkerk AO; Wilders R; van Ginneken AC
J Physiol; 2006 Jan; 570(Pt 2):237-50. PubMed ID: 16254012
[TBL] [Abstract][Full Text] [Related]
9. A novel SCN5A mutation associated with long QT-3: altered inactivation kinetics and channel dysfunction.
Rivolta I; Clancy CE; Tateyama M; Liu H; Priori SG; Kass RS
Physiol Genomics; 2002 Sep; 10(3):191-7. PubMed ID: 12209021
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms by which SCN5A mutation N1325S causes cardiac arrhythmias and sudden death in vivo.
Tian XL; Yong SL; Wan X; Wu L; Chung MK; Tchou PJ; Rosenbaum DS; Van Wagoner DR; Kirsch GE; Wang Q
Cardiovasc Res; 2004 Feb; 61(2):256-67. PubMed ID: 14736542
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of ventricular arrhythmogenesis in mice following targeted disruption of KCNE1 modelling long QT syndrome 5.
Thomas G; Killeen MJ; Gurung IS; Hakim P; Balasubramaniam R; Goddard CA; Grace AA; Huang CL
J Physiol; 2007 Jan; 578(Pt 1):99-114. PubMed ID: 17095567
[TBL] [Abstract][Full Text] [Related]
12. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes.
Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR
Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580
[TBL] [Abstract][Full Text] [Related]
13. Effects of sodium channel block with mexiletine to reverse action potential prolongation in in vitro models of the long term QT syndrome.
Sicouri S; Antzelevitch D; Heilmann C; Antzelevitch C
J Cardiovasc Electrophysiol; 1997 Nov; 8(11):1280-90. PubMed ID: 9395171
[TBL] [Abstract][Full Text] [Related]
14. Intracellular calcium attenuates late current conducted by mutant human cardiac sodium channels.
Potet F; Beckermann TM; Kunic JD; George AL
Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):933-41. PubMed ID: 26022185
[TBL] [Abstract][Full Text] [Related]
15. The heart on a chip: the role of realistic mathematical models of cardiac electrical activity in understanding and treating cardiac arrhythmias.
Nattel S
Heart Rhythm; 2007 Jun; 4(6):779-80. PubMed ID: 17556202
[No Abstract] [Full Text] [Related]
16. ATX-II effects on the apparent location of M cells in a computational model of a human left ventricular wedge.
Dos Santos RW; Otaviano Campos F; Neumann Ciuffo L; Nygren A; Giles W; Koch H
J Cardiovasc Electrophysiol; 2006 May; 17 Suppl 1():S86-S95. PubMed ID: 16686688
[TBL] [Abstract][Full Text] [Related]
17. Antiarrhythmic effect of IKr activation in a cellular model of LQT3.
Diness JG; Hansen RS; Nissen JD; Jespersen T; Grunnet M
Heart Rhythm; 2009 Jan; 6(1):100-6. PubMed ID: 19121808
[TBL] [Abstract][Full Text] [Related]
18. Insights into the molecular mechanisms of bradycardia-triggered arrhythmias in long QT-3 syndrome.
Clancy CE; Tateyama M; Kass RS
J Clin Invest; 2002 Nov; 110(9):1251-62. PubMed ID: 12417563
[TBL] [Abstract][Full Text] [Related]
19. Arrhythmogenic substrate and its modification by nicorandil in a murine model of long QT type 3 syndrome.
Hothi SS; Booth SW; Sabir IN; Killeen MJ; Simpson F; Zhang Y; Grace AA; Huang CL
Prog Biophys Mol Biol; 2008; 98(2-3):267-80. PubMed ID: 19351517
[TBL] [Abstract][Full Text] [Related]
20. Novel arrhythmogenic mechanism revealed by a long-QT syndrome mutation in the cardiac Na(+) channel.
Abriel H; Cabo C; Wehrens XH; Rivolta I; Motoike HK; Memmi M; Napolitano C; Priori SG; Kass RS
Circ Res; 2001 Apr; 88(7):740-5. PubMed ID: 11304498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
